Evelo Biosciences, Inc. Annual Operating Lease, Payments in USD from 2020 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Evelo Biosciences, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2020 to 2022.
  • Evelo Biosciences, Inc. Operating Lease, Payments for the quarter ending March 31, 2023 was $800K, unchanged year-over-year.
  • Evelo Biosciences, Inc. annual Operating Lease, Payments for 2022 was $3.1M, a 3.33% increase from 2021.
  • Evelo Biosciences, Inc. annual Operating Lease, Payments for 2021 was $3M, a 10% decline from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.